• Reuters
• 05 Feb, 2020

U.S. drugmaker Merck & Co Inc said on Wednesday it was planning to spin off its women's health, biosimilar drugs, and legacy products into a new publicly-traded company. Merck will retain its cancer drugs, including blockbuster cancer therapy Keytruda, vaccines, hospital, and animal health businesses, the company said.
Read more...